Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
Juan González‐Moreno, Dianna Quan(University of Michigan), Sorina Bădeliță, Jocelyn Inamo(Centre Hospitalier Universitaire de Martinique), Pritam Gupta(Pfizer (India)), Olga Azevedo(British Heart Foundation), Eun‐Seok Jeon, Alberta L. Warner(University of California, Los Angeles), Ivailo Tournev(Université Paris-Sud), Jonas Wixner(Umeå University), Hans Nienhuis(University Medical Center Groningen), Luca Gentile(University of Messina), Márcia Waddington‐Cruz(Université Paris-Sud), Miriam Freimer, José González‐Costello(British Heart Foundation), Michele Emdin(Scuola Superiore Sant'Anna), Igor Diemberger, Marco Luigetti(Università Cattolica del Sacro Cuore), Mazen Hanna(Cleveland Clinic), Oliver Glass(Pfizer (United States)), Doug Chapman(Pfizer (United States)), Yoshiki Sekijima(Shinshu University), Violaine Planté‐Bordeneuve(Université Paris-Est Créteil), David Slosky(Jisc), Daniel J. Lenihan(Saint Francis Medical Center), Mitsuharu Ueda(Kumamoto University), Fábio Barroso(Université Paris-Sud), Mathew S. Maurer(Alnylam Pharmaceuticals (United States)), Pablo García‐Pavía(Universidad Francisco de Vitoria), José Nativi Nicolau, Isabel Conceição(Université Paris-Sud), Scott L. Hummel(VA Ann Arbor Healthcare System), Arnt V. Kristen(Heidelberg University), Francisco Muñoz Beamud(Hospital Juan Ramón Jiménez), Brian Drachman(Penn Presbyterian Medical Center), Stephen S. Gottlieb(University of Maryland, Baltimore), Martha Grogan(Mayo Clinic in Arizona), Anna Mazzeo(University of Messina), Olivier Lairez(Hôpital Rangueil), Leslie Amass(Pfizer (United States)), Michael Polydefkis(Université Paris-Sud), Anna Hüsing‐Kabar(University Hospital Münster), Soon-Chai Low(Monash University Malaysia), Edward J. Miller(Yale University), Teresa Coelho(Universidade do Porto), Rayomand Press(Karolinska University Hospital), Angela Dispenzieri(Mayo Clinic), Robert Brunkhorst, Maria Alejandra Gonzalez Duarte Briseno(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán)
Cited by 24
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k